id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2016-0002-0008,DEA,DEA-2016-0002,"Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA Into Schedule I",Rule,,2016-09-06T04:00:00Z,2016,9,2016-09-06T04:00:00Z,,2016-09-06T14:47:40Z,2016-21345,0,0,09000064821d2f31
DEA-2016-0002-0003,DEA,DEA-2016-0002,HHS Letter,Supporting & Related Material,,2016-02-05T05:00:00Z,2016,2,,,2016-02-05T15:55:11Z,,0,0,0900006481e54543
DEA-2016-0002-0004,DEA,DEA-2016-0002,Four Synthetic Cannabinoids Economic Impact Analysis,Supporting & Related Material,,2016-02-05T05:00:00Z,2016,2,,,2016-02-05T17:19:22Z,,0,0,0900006481e54be0
DEA-2016-0002-0001,DEA,DEA-2016-0002,"Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I",Proposed Rule,,2016-02-05T05:00:00Z,2016,2,2016-02-05T05:00:00Z,2016-03-08T04:59:59Z,2016-02-29T21:00:42Z,2016-02305,0,0,0900006481e53b67
DEA-2016-0002-0002,DEA,DEA-2016-0002,Four Synthetic Cannabinoids  8-Factor,Supporting & Related Material,,2016-02-05T05:00:00Z,2016,2,,,2016-02-05T15:54:15Z,,0,0,0900006481e54540